Tumor self-seeding by circulating tumor cells in nude mouse models of human osteosarcoma and a preliminary study of its mechanisms

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 2, 2014, Pages 329-340

  Zhang, Yinglong ^a   Ma, Qiong ^a   Liu, Tao ^a   Ke, Shi ^b   Jiang, Kuo ^a   Wen, Yanhua ^a   Ma, Baoan ^a   Zhou, Yong ^a   Fan, Qingyu ^a   Qiu, Xiuchun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Circulating tumor cells; Cytokine; Metastasis; Nude mice; Osteosarcoma; Tumor self seeding

Indexed keywords

ANIMALS; BLOTTING, WESTERN; BONE NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; LUMINESCENT PROTEINS; MICE; MICE, NUDE; NEOPLASM SEEDING; NEOPLASTIC CELLS, CIRCULATING; OSTEOSARCOMA; RECEPTORS, INTERLEUKIN-6; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84895075019     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1561-7     Document Type: Article

References (52)

1. Aguirre-Ghiso JA (2010) On the theory of tumor self-seeding: implications for metastasis progression in humans. Breast Cancer Res 12:304
2. Ara T, Declerck YA (2010) Interleukin-6 in bone metastasis and cancer progression. Eur J Cancer 46:1223-1231
3. Avigad S, Cohen IJ, Zilberstein J, Liberzon E, Goshen Y, Ash S, Meller I, Kollender Y, Issakov J, Zaizov R et al (2004) The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors. Cancer 100:1053-1058
4. Bian ZY, Fan QM, Li G, Xu WT, Tang TT (2010) Human mesenchymal stem cells promote growth of osteosarcoma: involvement of interleukin-6 in the interaction between human mesenchymal stem cells and Saos-2. Cancer Sci 101:2554-2560
5. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184:1101-1109
6. Bromberg J (2002) Stat proteins and oncogenesis. J Clin Investig 109:1139-1142
7. Chen X, Yang TT, Wang W, Sun HH, Ma BA, Li CX, Ma Q, Yu Z, Fan QY (2009) Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials. Cytotechnology 61:37-44
8. Chou AJ, Merola PR, Wexler LH, Gorlick RG, Vyas YM, Healey JH, LaQuaglia MP, Huvos AG, Meyers PA (2005) Treatment of osteosarcoma at first recurrence after contemporary therapy: the Memorial Sloan-Kettering Cancer Center experience. Cancer 104:2214-2221
9. Chugh PE, Sin SH, Ozgur S, Henry DH, Menezes P, Griffith J, Eron JJ, Damania B, Dittmer DP (2013) Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog 9:e1003484
10. Comen E, Norton L, Massagué J (2011) Clinical implications of cancer self-seeding. Nat Rev Clin Oncol 8:369-377
11. Daw NC, Billups CA, Rodriguez-Galindo C, McCarville MB, Rao BN, Cain AM, Jenkins JJ, Neel MD, Meyer WH (2006) Metastatic osteosarcoma. Cancer 106:403-412
12. Eccles SA, Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742-1757
13. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31
14. Fukuda K, Kobayashi A, Watabe K (2012) The role of tumor-associated macrophage in tumor progression. Front Biosci (Schol Ed) 4:787-798
15. Gerges N, Jabado N (2010) Biomarkers in cancer micrometastasis: where are we at? Bioanalysis 2:881-899
16. Grunewald TG, Herbst SM, Heinze J, Burdach S (2011) Understanding tumor heterogeneity as functional compartments-superorganisms revisited. J Transl Med 9:79
17. Hahnfeldt P (2010) Significance of tumor self-seeding as an augmentation to the classic metastasis paradigm. Future Oncol 6:681-685
18. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1-20
19. Hong DS, Angelo LS, Kurzrock R (2007) Interleukin-6 and its receptor in cancer: implications for translational therapeutics. Cancer 110:1911-1928
20. Huang G, Yu L, Cooper LJ, Hollomon M, Huls H, Kleinerman ES (2012) Genetically modified T cells targeting interleukin-11 receptor α-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases. Cancer Res 72:271-281
21. Hussain SP, Harris CC (2007) Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 121:2373-2380
22. Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH, Ren L, Wong D, Korz W, Merzouk A et al (2008) Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 25:201-211
23. Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, Massagué J (2009) Tumor self-seeding by circulating cancer cells. Cell 139:1315-1326
24. Kong C, Hansen MF (2009) Biomarkers in osteosarcoma. Expert Opin Med Diagn 3:13-23
25. Krebs MG, Hou JM, Ward TH, Blackhall FH, Dive C (2010) Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol 2:351-365
26. Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R (2005) Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res 11:2561-2567
27. Leung CT, Brugge JS (2009) Tumor self-seeding: bidirectional flow of tumor cells. Cell 139:1226-1228
28. Lewis JJ, Leung D, Espat J, Woodruff JM, Brennan MF (2000) Effect of reresection in extremity soft tissue sarcoma. Ann Surg 231:655-663
29. Lewis VO, Ozawa MG, Deavers MT, Wang G, Shintani T, Arap W, Pasqualini R (2009) The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res 69:1995-1999
30. Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Pritchard J, Malpas JS, Baker AR, Kirkpatrick JA et al (1986) The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314:1600-1606
31. Marina N, Gebhardt M, Teot L, Gorlick R (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9:422-441
32. Mavroudis D (2010) Circulating cancer cells. Ann Oncol 21(Suppl 7):vii95-vii100
33. McQueen P, Ghaffar S, Guo Y, Rubin EM, Zi X, Hoang BH (2011) The Wnt signaling pathway: implications for therapy in osteosarcoma. Expert Rev Anticancer Ther 11:1223-1232
34. Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924-935
35. Miller IV, Raposo G, Welsch U, Prazeres da Costa O, Thiel U, Lebar M, Maurer M, Bender HU, von Luettichau I, Richter GH et al (2013) First identification of Ewing's sarcoma-derived extracellular vesicles and exploration of their biological and potential diagnostic implications. Biol Cell 105:289-303
36. Murphy PM (2001) Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345:833-835
37. Nicolini A, Carpi A, Rossi G (2006) Cytokines in breast cancer. Cytokine Growth Factor Rev 17:325-337
38. Nyberg P, Salo T, Kalluri R (2008) Tumor microenvironment and angiogenesis. Front Biosci 13:6537-6553
39. Perissinotto E, Cavalloni G, Leone F, Fonsato V, Mitola S, Grignani G, Surrenti N, Sangiolo D, Bussolino F, Piacibello W et al (2005) Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. Clin Cancer Res 11:490-497
40. Putoczki T, Ernst M (2010) More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. J Leukoc Biol 88:1109-1117
41. Reddy K, Zhou Z, Jia SF, Lee TH, Morales-Arias J, Cao Y, Kleinerman ES (2008) Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer 123:831-837
42. Reddy BY, Lim PK, Silverio K, Patel SA, Won BW, Rameshwar P (2012) The microenvironmental effect in the progression, metastasis, and dormancy of breast cancer: a model system within bone marrow. Int J Breast Cancer 2012:721659
43. Ritter J, Bielack SS (2010) Osteosarcoma. Ann Oncol 21(Suppl 7):vii320-vii325
44. Schleiermacher G, Peter M, Oberlin O, Philip T, Rubie H, Mechinaud F, Sommelet-Olive D, Landman-Parker J, Bours D, Michon J et al (2003) Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized Ewing tumor. J Clin Oncol 21:85-91
45. Skubitz KM, D'Adamo DR (2007) Sarcoma. Mayo Clin Proc 82:1409-1432
46. Sterling JA, Edwards JR, Martin TJ, Mundy GR (2011) Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone 48:6-15
47. Tu B, Du L, Fan QM, Tang Z, Tang TT (2012) STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma. Cancer Lett 325:80-88
48. Vendramini-Costa DB, Carvalho JE (2012) Molecular link mechanisms between inflammation and cancer. Curr Pharm Des 18:3831-3852
49. Whelan J, Seddon B, Perisoglou M (2006) Management of osteosarcoma. Curr Treat Options Oncol 7:444-455
50. Wong IH, Chan AT, Johnson PJ (2000) Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study. Clin Cancer Res 6:2183-2188
51. Xu WT, Bian ZY, Fan QM, Li G, Tang TT (2009) Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett 281:32-41
52. Zhang HG, Grizzle WE (2011) Exosomes and cancer: a newly described pathway of immune suppression. Clin Cancer Res 17:959-964